Biotechnik

BioEcho Life Sciences introduces the EchoLUTION™ Tissue RNA Kit for fast and reliable RNA extraction without phenol/chloroform

BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, has launched its latest product: the EchoLUTION Tissue RNA Kit — designed to streamline and optimize total RNA extraction from mammalian tissues, including challenging tissues such as muscle.

"We are thrilled to introduce the EchoLUTION Tissue RNA Kit," said Christiane Schlottbom, Director Marketing at BioEcho Life Sciences. "This innovative solution represents a significant advancement in RNA extraction technology, offering researchers unparalleled speed, efficiency, and reliability in their experiments. We believe that the EchoLUTION Tissue RNA Kit will greatly simplify the workflow of scientists working in diverse fields of molecular biology, as it provides high-quality RNA without the need for phenol/chloroform."

The EchoLUTION Tissue RNA Kit offers numerous advantages over traditional methods, providing researchers with unprecedented flexibility and versatility. The kit is suitable for a variety of fresh-frozen or stabilized tissues. This product significantly reduces processing time and increases efficiency in the laboratory. The single-step purification technology, combined with ultra-fast tissue lysis, allows complete extraction of 96 samples within 35 minutes. The result is a highly pure RNA free of contaminants and inhibitors, ensuring reliable and reproducible results in downstream applications such as RT-qPCR and RNA-seq.

Further, the EchoLUTION Tissue RNA Kit demonstrates the BioEcho commitment to sustainability and eco-conscious practices with up to 50 % less plastic consumption in comparison to other extraction methods and eliminating the need for hazardous reagents.

For more information about EchoLUTION Tissue RNA Kit and workflow, please visit www.bioecho.com/Tissue-RNA or contact BioEcho via email at contact@bioecho.de

Über die BioEcho Life Sciences GmbH

BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our patented EchoLUTION™ technology enables the fastest DNA and RNA extraction on the market – in just one single step. It reduces the associated plastic consumption by up to 70 %.
BioEcho was founded in 2016 by leading industry experts. The headquarter in Cologne, Germany, is certified according to ISO 9001 and ISO 13485.

BioEcho. The Nucleic Acid Experts.

Firmenkontakt und Herausgeber der Meldung:

BioEcho Life Sciences GmbH
Nattermannallee 1
50829 Köln
Telefon: +49 221 998897 0
http://www.bioecho.de/

Ansprechpartner:
Dr Laura Torres Benito
Scientific Communications Manager
Telefon: +49 221 998897-24
E-Mail: laura.torres.benito@bioecho.de
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel